392 POSTER A phase I/II multicenter trial of BMS-690514, an...

European Journal of Cancer Supplements 2008 Vol. 6; Iss. 12

392 POSTER A phase I/II multicenter trial of BMS-690514, an ErbB-VEGFR inhibitor, in patients with advanced NSCLC who are erlotinib naive or previously treated with erlotinib

J.C. Soria, E. Felip, R. Herbst, N. Hannah, S. laurie, J.P. Armand, F. Shepherd, D. Berman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72326-7
File:
PDF, 63 KB
english, 2008
Conversion to is in progress
Conversion to is failed